{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:35:33Z","timestamp":1790804133350,"version":"4.1.0"},"reference-count":117,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,16]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>B cells expressing the IGHV4-34 gene sit at the center of a web of B-cell functions, ranging from natural antibodies induced by infection to autoimmunity and tumors. Tracking via the 9G4 monoclonal antibody (MoAb) specifically directed against the unique flag sequences in the first framework region 1 (FR1) of IGHV4-34, allows insight into the evolving nature and multiple functions of B cells expressing a single IGHV gene. IGHV4-34+ B cells are found early in development, and the expansion indicative of a superantigenic drive occurs with increasing age. IGHV4-34+ B cells secrete immunoglobulin M (IgM) in various hematologic conditions, including the mandatory association with cold agglutinins, and the transient expansions of usage (not always overt agglutination) are observed in Epstein-Barr virus, cytomegalovirus, Mycoplasma pneumoniae, and other infections. Perhaps connected to that, certain autoimmune conditions, such as systemic lupus erythematosus, show increases in IGHV4-34 expression, which correlate with disease flares. Intriguingly, there is preferential usage of IGHV4-34 in a wide range of lymphomas and in the IgG variant of chronic lymphocytic leukemia, suggestive of an autoantigenic drive. Structurally, both the interaction of the 9G4 MoAb and the ability of the IGHV4-34\u2013encoded protein to bind to N-acetyl lactosamine\u2013containing sequences, rely on hydrophobic amino acids located in 2 positions of the looped FR1 sequence of the variable domain. This offers a focused site for blockade. IGHV4-34 is a paradigm of the plasticity of B cells, of interaction with potential autoantigens, and of their subversion in tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025032357","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:05:51Z","timestamp":1768939551000},"page":"1793-1803","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["The singularity of IGHV4-34 links infection, autoimmunity, and B-cell tumors"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0933-5021","authenticated-orcid":false,"given":"Freda K.","family":"Stevenson","sequence":"first","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[{"name":"2Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"12","key":"2026041611213780200_bib1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"issue":"2","key":"2026041611213780200_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1182\/blood.V68.2.430.430","article-title":"Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors","volume":"68","author":"Stevenson","year":"1986","journal-title":"Blood"},{"issue":"6","key":"2026041611213780200_bib3","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1078-0432.CCR-05-2164","article-title":"Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia","volume":"12","author":"Potter","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"5-6","key":"2026041611213780200_bib4","first-page":"299","article-title":"Use of a cross reacting anti-idiotype to identify normal counterparts of neoplastic cells","volume":"30","author":"Stevenson","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"issue":"1","key":"2026041611213780200_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1989.tb07643.x","article-title":"Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity","volume":"72","author":"Stevenson","year":"1989","journal-title":"Br J Haematol"},{"issue":"7","key":"2026041611213780200_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI200112462","article-title":"Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance","volume":"108","author":"Pugh-Bernard","year":"2001","journal-title":"J Clin Invest"},{"issue":"2","key":"2026041611213780200_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4049\/jimmunol.151.2.1051","article-title":"Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment","volume":"151","author":"Chapman","year":"1993","journal-title":"J Immunol"},{"issue":"1","key":"2026041611213780200_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/imr.12754","article-title":"The continuing story of T-cell independent antibodies","volume":"288","author":"Allman","year":"2019","journal-title":"Immunol Rev"},{"issue":"6","key":"2026041611213780200_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0896-8411(05)80042-3","article-title":"Isolation and EBV-transformation of a minor population of normal human tonsillar B cells bearing a cold agglutinin-associated idiotope","volume":"3","author":"Smith","year":"1990","journal-title":"J Autoimmun"},{"issue":"7","key":"2026041611213780200_bib10","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.172.7.4298","article-title":"Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45\/B220 on the surface of human B lymphocytes","volume":"172","author":"Cappione","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"2026041611213780200_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12016-019-08746-9","article-title":"Natural antibodies: from first-line defense against pathogens to perpetual immune homeostasis","volume":"58","author":"Maddur","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026041611213780200_bib12","doi-asserted-by":"crossref","first-page":"140037","DOI":"10.1016\/j.ijbiomac.2025.140037","article-title":"Profiling the broad antibody diversity of lymphatic filariasis immune antibody repertoire by deep sequencing","volume":"290","author":"Lim","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"2026041611213780200_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41426-018-0175-1","article-title":"Identification of a novel broadly HIV-1-neutralizing antibody from a CRF01_AE-infected Chinese donor","volume":"7","author":"Ju","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"10","key":"2026041611213780200_bib14","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.4049\/jimmunol.1600491","article-title":"The Regulation of inherently autoreactive VH4-34-expressing B cells in individuals living in a malaria-endemic area of West Africa","volume":"197","author":"Hart","year":"2016","journal-title":"J Immunol"},{"issue":"12","key":"2026041611213780200_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"issue":"12","key":"2026041611213780200_bib16","doi-asserted-by":"crossref","first-page":"e70073","DOI":"10.1002\/jmv.70073","article-title":"Discovery of a novel public antibody lineage correlated with inactivated SARS-CoV-2 vaccine and the resultant neutralization activity","volume":"96","author":"Wang","year":"2024","journal-title":"J Med Virol"},{"issue":"4","key":"2026041611213780200_bib17","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1128\/JVI.02127-10","article-title":"Capturing the natural diversity of the human antibody response against vaccinia virus","volume":"85","author":"Lantto","year":"2011","journal-title":"J Virol"},{"issue":"7","key":"2026041611213780200_bib18","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.4049\/jimmunol.169.7.3777","article-title":"Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen","volume":"169","author":"Potter","year":"2002","journal-title":"J Immunol"},{"issue":"4 pt 2","key":"2026041611213780200_bib19","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1164\/ajrccm\/154.4_Pt_2.S133","article-title":"Carbohydrate recognition by Mycoplasma pneumoniae and pathologic consequences","volume":"154","author":"Feizi","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2026041611213780200_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1537-2995.1991.31791368339.x","article-title":"Sia-b1 and I antigens recognized by Mycoplasma pneumoniae-induced human cold agglutinins","volume":"31","author":"Roelcke","year":"1991","journal-title":"Transfusion (Paris)"},{"issue":"6","key":"2026041611213780200_bib21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.molimm.2007.10.009","article-title":"Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma","volume":"45","author":"McCann","year":"2008","journal-title":"Mol Immunol"},{"issue":"9","key":"2026041611213780200_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/ard.57.9.566","article-title":"Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus","volume":"57","author":"Isenberg","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2026041611213780200_bib23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jaut.1993.1066","article-title":"Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus","volume":"6","author":"Stevenson","year":"1993","journal-title":"J Autoimmun"},{"issue":"2","key":"2026041611213780200_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3233\/HAB-1995-6203","article-title":"Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene: a possible link between infection and lupus","volume":"6","author":"Spellerberg","year":"1995","journal-title":"Hum Antibodies Hybridomas"},{"issue":"10","key":"2026041611213780200_bib25","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.4049\/jimmunol.1202263","article-title":"Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus","volume":"191","author":"Richardson","year":"2013","journal-title":"J Immunol"},{"issue":"12","key":"2026041611213780200_bib26","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/art.38138","article-title":"9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus","volume":"65","author":"Jenks","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2026041611213780200_bib27","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1172\/JCI24179","article-title":"Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus","volume":"115","author":"Cappione","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"2026041611213780200_bib28","first-page":"298","article-title":"B lymphocytopenia in infectious mononucleosis","volume":"43","author":"Sumaya","year":"1981","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2026041611213780200_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-065X.2010.00936.x","article-title":"Molecular underpinning of B-cell anergy","volume":"237","author":"Yarkoni","year":"2010","journal-title":"Immunol Rev"},{"key":"2026041611213780200_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.1997.tb52044.x","article-title":"Balancing immunity, autoimmunity, and self-tolerance","volume":"815","author":"Goodnow","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"2026041611213780200_bib31","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status","volume":"109","author":"Mockridge","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2026041611213780200_bib32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3324\/haematol.2013.098384","article-title":"The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy","volume":"99","author":"Packham","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"2026041611213780200_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20080611","article-title":"Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors","volume":"206","author":"Duty","year":"2009","journal-title":"J Exp Med"},{"issue":"6","key":"2026041611213780200_bib34","doi-asserted-by":"crossref","first-page":"e20212553","DOI":"10.1084\/jem.20212553","article-title":"SARS-CoV-2 infection relaxes peripheral B cell tolerance","volume":"219","author":"Castleman","year":"2022","journal-title":"J Exp Med"},{"issue":"1","key":"2026041611213780200_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12808","article-title":"Clonal redemption and clonal anergy as mechanisms to balance B cell tolerance and immunity","volume":"292","author":"Burnett","year":"2019","journal-title":"Immunol Rev"},{"issue":"3","key":"2026041611213780200_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","article-title":"Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma","volume":"99","author":"Randen","year":"2014","journal-title":"Haematologica"},{"key":"2026041611213780200_bib37","doi-asserted-by":"crossref","first-page":"1123029","DOI":"10.3389\/fonc.2023.1123029","article-title":"Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories","volume":"13","author":"Gkoliou","year":"2023","journal-title":"Front Oncol"},{"issue":"2","key":"2026041611213780200_bib38","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","article-title":"Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study","volume":"1","author":"Baliakas","year":"2014","journal-title":"Lancet Haematol"},{"issue":"1","key":"2026041611213780200_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.4933","article-title":"Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma","volume":"243","author":"Moody","year":"2017","journal-title":"J Pathol"},{"issue":"11","key":"2026041611213780200_bib40","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3324\/haematol.2019.231027","article-title":"Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG)","volume":"105","author":"Jaramillo","year":"2020","journal-title":"Haematologica"},{"issue":"17","key":"2026041611213780200_bib41","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1158\/1078-0432.CCR-16-3100","article-title":"Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: Shared and distinct immunogenetic features and clinical outcomes","volume":"23","author":"Xochelli","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2026041611213780200_bib42","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2026041611213780200_bib43","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"10","key":"2026041611213780200_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood.2020010029","article-title":"Exploring the pathways to chronic lymphocytic leukemia","volume":"138","author":"Stevenson","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2026041611213780200_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.seminhematol.2023.12.005","article-title":"B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: key to understanding disease biology and stratifying patients","volume":"61","author":"Agathangelidis","year":"2024","journal-title":"Semin Hematol"},{"issue":"8","key":"2026041611213780200_bib46","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"issue":"10","key":"2026041611213780200_bib47","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2020007039","article-title":"Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL","volume":"137","author":"Agathangelidis","year":"2021","journal-title":"Blood"},{"issue":"7","key":"2026041611213780200_bib48","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"issue":"11-12","key":"2026041611213780200_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2119\/2008-00102.Catera","article-title":"Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation","volume":"14","author":"Catera","year":"2008","journal-title":"Mol Med"},{"issue":"6","key":"2026041611213780200_bib50","doi-asserted-by":"crossref","first-page":"e65203","DOI":"10.1371\/journal.pone.0065203","article-title":"IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope","volume":"8","author":"Que","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"2026041611213780200_bib51","doi-asserted-by":"crossref","first-page":"e65203","DOI":"10.1371\/journal.pone.0065203","article-title":"IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde\u2013acetaldehyde adduct, an immunodominant oxidation-specific epitope","volume":"8","author":"Que","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"2026041611213780200_bib52","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1084\/jem.152.6.1484","article-title":"Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes","volume":"152","author":"Stevenson","year":"1980","journal-title":"J Exp Med"},{"issue":"suppl 2","key":"2026041611213780200_bib53","first-page":"S26","article-title":"Unusual complications in the management of chronic lymphocytic leukemia","volume":"97","author":"Gordon","year":"2022","journal-title":"Am J Hematol"},{"issue":"2","key":"2026041611213780200_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1078-0432.CCR-13-1993","article-title":"IgG-switched cell has a distinct immunogenetic signature from the common md variant: ontogenetic implications","volume":"20","author":"Vardi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2026041611213780200_bib55","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","article-title":"Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis","volume":"111","author":"Murray","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2026041611213780200_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood-2008-07-166868","article-title":"Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia","volume":"113","author":"Hadzidimitriou","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2026041611213780200_bib57","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/leu.2008.379","article-title":"Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors","volume":"23","author":"Kostareli","year":"2009","journal-title":"Leukemia"},{"issue":"4","key":"2026041611213780200_bib58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","article-title":"Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia","volume":"200","author":"Messmer","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"2026041611213780200_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2026041611213780200_bib60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-3083.1998.00426.x","article-title":"Comparison of the frequencies of arginines in heavy chain CDR3 of antibodies expressed in the primary B-cell repertoires of autoimmune-prone and normal mice","volume":"48","author":"Krishnan","year":"1998","journal-title":"Scand J Immunol"},{"issue":"7","key":"2026041611213780200_bib61","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/1521-4141(200007)30:7<2015::AID-IMMU2015>3.0.CO;2-5","article-title":"Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA","volume":"30","author":"Li","year":"2000","journal-title":"Eur J Immunol"},{"issue":"2","key":"2026041611213780200_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s000180300026","article-title":"Anti-DNA antibodies: aspects of structure and pathogenicity","volume":"60","author":"Jang","year":"2003","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"2026041611213780200_bib63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-3083.2000.00654.x","article-title":"Recognition of auto- and exoantigens by V4-34 gene encoded antibodies","volume":"51","author":"Bhat","year":"2000","journal-title":"Scand J Immunol"},{"issue":"10","key":"2026041611213780200_bib64","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.4049\/jimmunol.1202263","article-title":"Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus","volume":"191","author":"Richardson","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"2026041611213780200_bib65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2119\/molmed.2014.00140","article-title":"An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4","volume":"20","author":"Sutton","year":"2015","journal-title":"Mol Med"},{"issue":"7","key":"2026041611213780200_bib66","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/leu.2010.90","article-title":"Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution","volume":"24","author":"Kostareli","year":"2010","journal-title":"Leukemia"},{"issue":"20","key":"2026041611213780200_bib67","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1182\/blood-2009-05-221309","article-title":"Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen","volume":"114","author":"Sutton","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2026041611213780200_bib68","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2119\/molmed.2013.00042","article-title":"Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34\/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence","volume":"19","author":"Sutton","year":"2013","journal-title":"Mol Med"},{"issue":"S3","key":"2026041611213780200_bib69","doi-asserted-by":"crossref","first-page":"e7074446","DOI":"10.1097\/01.HS9.0000969324.70744.46","article-title":"Immunogenetics and antigen reactivity profiling contribute to unravelling the ontogeny of cell stereotyped subset #4 [abstract]","volume":"7","author":"Iatrou","year":"2023","journal-title":"Hemasphere"},{"key":"2026041611213780200_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/molmed.2017.00003","article-title":"Binding of CLL subset 4 B cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutation","volume":"23","author":"Catera","year":"2017","journal-title":"Mol Med"},{"issue":"6","key":"2026041611213780200_bib71","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"Herv\u00e9","year":"2005","journal-title":"J Clin Invest"},{"issue":"10","key":"2026041611213780200_bib72","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.1502297","article-title":"B cell anergy modulated by TLR1\/2 and the miR-17\u223c92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset #4","volume":"196","author":"Ntoufa","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"2026041611213780200_bib73","doi-asserted-by":"crossref","first-page":"15746","DOI":"10.1038\/ncomms15746","article-title":"Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia","volume":"8","author":"Minici","year":"2017","journal-title":"Nat Commun"},{"issue":"7314","key":"2026041611213780200_bib74","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nature09357","article-title":"Oligomeric organization of the B-cell antigen receptor on resting cells","volume":"467","author":"Yang","year":"2010","journal-title":"Nature"},{"key":"2026041611213780200_bib75","doi-asserted-by":"crossref","first-page":"1253412","DOI":"10.3389\/fimmu.2023.1253412","article-title":"Discovering immunoreceptor coupling and organization motifs","volume":"14","author":"Reth","year":"2023","journal-title":"Front Immunol"},{"issue":"21","key":"2026041611213780200_bib76","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Primary CNS lymphoma","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"2026041611213780200_bib77","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1442-9071.2008.01843.x","article-title":"Understanding intraocular lymphomas","volume":"36","author":"Coupland","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"2026041611213780200_bib78","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"issue":"6769","key":"2026041611213780200_bib79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"7277","key":"2026041611213780200_bib80","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"44","key":"2026041611213780200_bib81","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2026041611213780200_bib82","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajpath.2012.07.028","article-title":"Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype","volume":"181","author":"Sebasti\u00e1n","year":"2012","journal-title":"Am J Pathol"},{"issue":"5","key":"2026041611213780200_bib83","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.V94.5.1738","article-title":"VH gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity","volume":"94","author":"Thompsett","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2026041611213780200_bib84","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0002-9440(10)65526-5","article-title":"Primary central nervous system lymphomas are derived from germinal- center B cells and show a preferential usage of the V4-34 gene segment","volume":"155","author":"Montesinos-Rongen","year":"1999","journal-title":"Am J Pathol"},{"issue":"3-4","key":"2026041611213780200_bib85","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10428190109057993","article-title":"Primary central nervous system lymphomas express Vh genes with intermediate to high somatic mutations","volume":"41","author":"Sekita","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2026041611213780200_bib86","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1349-7006.2002.tb01239.x","article-title":"Primary malignant lymphoma of the brain: mutation pattern of rearranged immunoglobulin heavy chain gene","volume":"93","author":"Endo","year":"2002","journal-title":"Jpn J Cancer Res"},{"issue":"19","key":"2026041611213780200_bib87","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood-2008-09-179366","article-title":"Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development","volume":"113","author":"McCann","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2026041611213780200_bib88","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2141.2007.06744.x","article-title":"Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas","volume":"138","author":"Malumbres","year":"2007","journal-title":"Br J Haematol"},{"issue":"10","key":"2026041611213780200_bib89","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1167\/iovs.05-0401","article-title":"Molecular analysis of immunoglobulin genes in primary intraocular lymphoma","volume":"46","author":"Coupland","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"2026041611213780200_bib90","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/bloodadvances.2019000980","article-title":"Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire","volume":"4","author":"Belhouachi","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2026041611213780200_bib91","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"15","key":"2026041611213780200_bib92","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"2026041611213780200_bib93","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"2","key":"2026041611213780200_bib94","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"3","key":"2026041611213780200_bib95","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/leu.2014.264","article-title":"The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing","volume":"29","author":"Vater","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"2026041611213780200_bib96","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/nan.12259","article-title":"Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas","volume":"42","author":"Nakamura","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"2026041611213780200_bib97","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41467-022-30050-y","article-title":"The genomic and transcriptional landscape of primary central nervous system lymphoma","volume":"13","author":"Radke","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"2026041611213780200_bib98","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.annonc.2022.11.002","article-title":"Molecular and clinical diversity in primary central nervous system lymphoma","volume":"34","author":"Hern\u00e1ndez-Verdin","year":"2023","journal-title":"Ann Oncol"},{"issue":"12","key":"2026041611213780200_bib99","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/NEN.0000000000000133","article-title":"Immunoglobulin repertoire of primary lymphomas of the central nervous system","volume":"73","author":"Montesinos-Rongen","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"2026041611213780200_bib100","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.4049\/jimmunol.1402341","article-title":"Primary central nervous system (CNS) lymphoma B cell receptors recognize CNS proteins","volume":"195","author":"Montesinos-Rongen","year":"2015","journal-title":"J Immunol"},{"issue":"26","key":"2026041611213780200_bib101","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2018-03-836932","article-title":"Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma","volume":"132","author":"Thurner","year":"2018","journal-title":"Blood"},{"issue":"25","key":"2026041611213780200_bib102","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1182\/blood.2023020911","article-title":"Primary large B-cell lymphomas of immune-privileged sites","volume":"144","author":"Roschewski","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2026041611213780200_bib103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41572-023-00439-0","article-title":"Primary central nervous system lymphoma","volume":"9","author":"Ferreri","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"2026041611213780200_bib104","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood.2020008520","article-title":"EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity","volume":"137","author":"Gandhi","year":"2021","journal-title":"Blood"},{"issue":"13","key":"2026041611213780200_bib105","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1182\/bloodadvances.2022009521","article-title":"Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS","volume":"7","author":"Guney","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"2026041611213780200_bib106","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3324\/haematol.12705","article-title":"Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin\u2019s lymphoma reveals implications for disease pathogenesis and histogenesis","volume":"93","author":"Capello","year":"2008","journal-title":"Haematologica"},{"issue":"8083","key":"2026041611213780200_bib107","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41586-025-09378-0","article-title":"EBV induces CNS homing of B cells attracting inflammatory T cells","volume":"646","author":"L\u00e4derach","year":"2025","journal-title":"Nature"},{"issue":"12","key":"2026041611213780200_bib108","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood.2023022703","article-title":"The essential microenvironmental role of oligomannoses specifically inserted into the antigen-binding sites of lymphoma cells","volume":"143","author":"Stevenson","year":"2024","journal-title":"Blood"},{"issue":"11","key":"2026041611213780200_bib109","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","article-title":"Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases","volume":"118","author":"Hadzidimitriou","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2026041611213780200_bib110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/path.5209","article-title":"Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations","volume":"247","author":"Xochelli","year":"2019","journal-title":"J Pathol"},{"issue":"7","key":"2026041611213780200_bib111","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","article-title":"Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: Ontogenetic implications","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"issue":"19","key":"2026041611213780200_bib112","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1182\/blood.2024025794","article-title":"EMZL at various sites: learning from each other","volume":"145","author":"Du","year":"2025","journal-title":"Blood"},{"issue":"9","key":"2026041611213780200_bib113","doi-asserted-by":"crossref","first-page":"e202402841","DOI":"10.26508\/lsa.202402841","article-title":"Distinct groups of autoantigens as drivers of ocular adnexal MALT lymphoma pathogenesis","volume":"7","author":"Bende","year":"2024","journal-title":"Life Sci Alliance"},{"issue":"12","key":"2026041611213780200_bib114","doi-asserted-by":"crossref","first-page":"e29114","DOI":"10.1371\/journal.pone.0029114","article-title":"Biased use of the IGHV4 family and evidence for antigen selection in chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"2026041611213780200_bib115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/bloodadvances.2016000794","article-title":"High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis","volume":"1","author":"Lombardo","year":"2017","journal-title":"Blood Adv"},{"issue":"12","key":"2026041611213780200_bib116","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2026041611213780200_bib117","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.leukres.2014.01.001","article-title":"Analysis of the IGHV region in Burkitt\u2019s lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis","volume":"38","author":"Baptista","year":"2014","journal-title":"Leuk Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/16\/1793\/2513190\/blood_bld-2025-032357-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/16\/1793\/2513190\/blood_bld-2025-032357-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:21:54Z","timestamp":1776352914000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/16\/1793\/566126\/The-singularity-of-IGHV4-34-links-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":117,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,4,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025032357","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,16]]},"published":{"date-parts":[[2026,4,16]]}}}